「and」の検索結果
113件：26～30件目を表示
-
千寿製薬株式会社
新闻 2026年06月01日 Launch of Distribution of 3in1Smart and SPM-700（PDF） 2026年04月06日 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（...
https://www.senju.co.jp/chinese/ -
Supplement business | Business Activities | About Senju | SENJU Pharmaceutical
Senju Pharmaceutical, as a pioneer of ophthalmic drugs, has long engaged in developing prescription and OTC drugs to contribute to the health of all people. As our next mission, we have found a way to...
https://www.senju.co.jp/english/about/business/ec.html -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Atsuhiro Kanda ARVO 2026 開催日：2026年5月３日～2026年5月7日 開催地：Denver, Colorado, United States of America Development of...
http://www.senju.co.jp/english/rd/society/ -
DS, et al. The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target. Retina. 2017;37(5):819-835. 2 Cheung, C.M.G., Ch...
https://www.senju.co.jp/system/files/content_news/2025-11/JPN_20251127.pdf -
Meetings of the Minds | Research & Development | SENJU Pharmaceutica
, motugivatrep, on the inflammatory response in dendritic cells Tsukasa Yagi, Mari Isomi, Atsuhiro Kanda ARVO 2026 開催日：2026年5月３日～2026年5月7日 開催地：Denver, Colorado, United States of America Development of...
https://www.senju.co.jp/english/rd/society/